×
S&P 500   3,895.35 (+1.31%)
DOW   31,341.12 (+0.98%)
QQQ   293.85 (+1.75%)
AAPL   145.83 (+2.04%)
MSFT   267.80 (+0.60%)
META   171.41 (+0.97%)
GOOGL   2,345.08 (+2.34%)
AMZN   116.04 (+1.50%)
TSLA   726.80 (+4.55%)
NVDA   157.93 (+4.38%)
NIO   22.35 (+7.30%)
BABA   123.78 (+3.91%)
AMD   79.27 (+5.20%)
MU   58.52 (+2.00%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.35 (+1.27%)
F   11.58 (+4.70%)
DIS   97.04 (+1.00%)
AMC   13.94 (+10.90%)
PFE   53.10 (+0.66%)
PYPL   74.67 (+1.95%)
NFLX   189.10 (+2.74%)
S&P 500   3,895.35 (+1.31%)
DOW   31,341.12 (+0.98%)
QQQ   293.85 (+1.75%)
AAPL   145.83 (+2.04%)
MSFT   267.80 (+0.60%)
META   171.41 (+0.97%)
GOOGL   2,345.08 (+2.34%)
AMZN   116.04 (+1.50%)
TSLA   726.80 (+4.55%)
NVDA   157.93 (+4.38%)
NIO   22.35 (+7.30%)
BABA   123.78 (+3.91%)
AMD   79.27 (+5.20%)
MU   58.52 (+2.00%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.35 (+1.27%)
F   11.58 (+4.70%)
DIS   97.04 (+1.00%)
AMC   13.94 (+10.90%)
PFE   53.10 (+0.66%)
PYPL   74.67 (+1.95%)
NFLX   189.10 (+2.74%)
S&P 500   3,895.35 (+1.31%)
DOW   31,341.12 (+0.98%)
QQQ   293.85 (+1.75%)
AAPL   145.83 (+2.04%)
MSFT   267.80 (+0.60%)
META   171.41 (+0.97%)
GOOGL   2,345.08 (+2.34%)
AMZN   116.04 (+1.50%)
TSLA   726.80 (+4.55%)
NVDA   157.93 (+4.38%)
NIO   22.35 (+7.30%)
BABA   123.78 (+3.91%)
AMD   79.27 (+5.20%)
MU   58.52 (+2.00%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.35 (+1.27%)
F   11.58 (+4.70%)
DIS   97.04 (+1.00%)
AMC   13.94 (+10.90%)
PFE   53.10 (+0.66%)
PYPL   74.67 (+1.95%)
NFLX   189.10 (+2.74%)
S&P 500   3,895.35 (+1.31%)
DOW   31,341.12 (+0.98%)
QQQ   293.85 (+1.75%)
AAPL   145.83 (+2.04%)
MSFT   267.80 (+0.60%)
META   171.41 (+0.97%)
GOOGL   2,345.08 (+2.34%)
AMZN   116.04 (+1.50%)
TSLA   726.80 (+4.55%)
NVDA   157.93 (+4.38%)
NIO   22.35 (+7.30%)
BABA   123.78 (+3.91%)
AMD   79.27 (+5.20%)
MU   58.52 (+2.00%)
CGC   2.67 (+0.75%)
T   21.17 (+0.38%)
GE   62.35 (+1.27%)
F   11.58 (+4.70%)
DIS   97.04 (+1.00%)
AMC   13.94 (+10.90%)
PFE   53.10 (+0.66%)
PYPL   74.67 (+1.95%)
NFLX   189.10 (+2.74%)
NASDAQ:BLCM

Bellicum Pharmaceuticals News Headlines

$1.22
-0.16 (-11.59%)
(As of 07/7/2022 11:46 AM ET)
Add
Compare
Today's Range
$1.22
$1.22
50-Day Range
$1.02
$1.70
52-Week Range
$1.00
$4.04
Volume
2,139 shs
Average Volume
20,839 shs
Market Capitalization
$10.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Get Bellicum Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter.

BLCM Media Mentions By Week

BLCM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BLCM
News Sentiment

0.00

0.77

Average
Medical
News Sentiment

BLCM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BLCM Articles
This Week

1

0

BLCM Articles
Average Week



BLCM Stock News Headlines Today

SourceHeadline
MarketBeat logoStockNews.com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)
americanbankingnews.com - July 2 at 3:58 AM
MarketBeat logoBellicum Pharmaceuticals (NASDAQ:BLCM) Now Covered by Analysts at StockNews.com
americanbankingnews.com - June 23 at 3:18 AM
MarketBeat logoStockNews.com Initiates Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)
americanbankingnews.com - June 16 at 2:52 AM
seekingalpha.com logoBellicum Pharmaceuticals GAAP EPS of -$0.25 beats by $0.42
seekingalpha.com - May 13 at 2:26 AM
finance.yahoo.com logoBellicum Reports First Quarter 2022 Financial Results and Provides Operational Update
finance.yahoo.com - May 13 at 2:26 AM
finance.yahoo.com logoBellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
finance.yahoo.com - March 24 at 4:52 PM
benzinga.com logoLadenburg Thalmann Initiates Coverage On Bellicum Pharmaceuticals with Buy Rating, Announces Price Target of $5
benzinga.com - February 16 at 12:22 PM
finance.yahoo.com logoBellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
finance.yahoo.com - January 26 at 6:08 PM
finance.yahoo.com logoBellicum Regains Compliance with Nasdaq Continued Listing Requirements
finance.yahoo.com - December 13 at 6:11 PM
finance.yahoo.com logoSumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021
finance.yahoo.com - December 10 at 1:11 PM
msn.com logoBellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
msn.com - December 7 at 4:48 AM
markets.businessinsider.com logoBellicum Reports Positive Interim Data From Phase 1/2 GoCAR-T Trials - Quick Facts
markets.businessinsider.com - December 6 at 12:45 PM
finance.yahoo.com logoBellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Market
finance.yahoo.com - December 6 at 7:44 AM
bizjournals.com logoK2 BioLabs hiring, expanding contract research offerings for biotech, pharma startups
bizjournals.com - December 2 at 6:56 PM
finance.yahoo.com logoBellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
finance.yahoo.com - November 4 at 7:52 PM
finance.yahoo.com logoBellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 3 at 3:46 PM
finance.yahoo.com logoBellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
finance.yahoo.com - September 1 at 6:25 PM
finance.yahoo.com logoBellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
finance.yahoo.com - August 12 at 4:49 PM
nasdaq.com logoBellicum Pharmaceuticals, Inc. Common Stock (BLCM)
nasdaq.com - July 16 at 11:22 PM
finance.yahoo.com logoBellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety Switch
finance.yahoo.com - June 28 at 8:51 AM
finance.yahoo.com logoShould I Avoid Bellicum Pharmaceuticals Inc (BLCM)?
finance.yahoo.com - June 13 at 2:54 PM
bizjournals.com logoK2bio coworking research facility for biotech, pharma startups opening this summer
bizjournals.com - June 11 at 9:31 AM
nasdaq.com logoIt's Unlikely That Bellicum Pharmaceuticals, Inc.'s (NASDAQ:BLCM) CEO Will See A Huge Pay Rise This Year
nasdaq.com - June 9 at 7:02 AM
uk.finance.yahoo.com logoBellicum Pharmaceuticals Stock Shows Every Sign Of Being Significantly Overvalued
uk.finance.yahoo.com - April 17 at 2:41 AM
markets.businessinsider.com logoBellicum Pharmaceuticals Inc Registered Shs hosts conference call for investors
markets.businessinsider.com - March 26 at 3:12 PM
finance.yahoo.com logoBellicum to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
finance.yahoo.com - March 23 at 6:17 PM
marketwatch.com logoBellicum Announces First Reported Use of CaspaCIDe(R) Safety Switch to Mitigate CAR-T Cell Toxicity
marketwatch.com - March 4 at 9:26 PM
finance.yahoo.com logoBellicum Shares Are Trading Higher On First Reported Positive Clinical Use Of iC9 Safety Switch
finance.yahoo.com - March 4 at 1:25 PM
finance.yahoo.com logoBellicum Announces First Reported Use of CaspaCIDe® Safety Switch to Mitigate CAR-T Cell Toxicity
finance.yahoo.com - March 4 at 8:25 AM
finance.yahoo.com logoPonce Therapeutics Inc. Commences First R & D Program in Anti-Aging Products for Skin
finance.yahoo.com - February 8 at 10:17 AM
benzinga.com logoBellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
benzinga.com - January 28 at 8:29 PM
finance.yahoo.com logoBellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
finance.yahoo.com - January 28 at 8:29 PM
finance.yahoo.com logoBellicum Pharmaceuticals (BLCM) Upgraded to Buy: Here's Why
finance.yahoo.com - December 25 at 2:44 PM
benzinga.com logoBellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
benzinga.com - December 10 at 4:04 PM
finance.yahoo.com logoBellicum Enrolls First Patient in Phase 1/2 Clinical Trial for BPX-603
finance.yahoo.com - December 10 at 4:04 PM
finance.yahoo.com logoFDA places clinical hold on Bellicum's cancer therapy
finance.yahoo.com - December 7 at 6:15 PM
finance.yahoo.com logoBellicum Reports Clinical Hold Placed on BPX-601 Phase 1/2 Clinical Trial
finance.yahoo.com - December 7 at 7:42 AM
finance.yahoo.com logoIs Bellicum Pharmaceuticals Inc (BLCM) A Good Stock To Buy?
finance.yahoo.com - November 27 at 8:52 PM
finance.yahoo.com logoBellicum Pharmaceuticals (BLCM) Upgraded to Buy: Here's What You Should Know
finance.yahoo.com - November 20 at 1:13 PM
finance.yahoo.com logoBellicum Reports Third Quarter 2020 Financial Results and Provides Operational Update
finance.yahoo.com - November 5 at 7:55 PM
finance.yahoo.com logoBellicum Pharmaceuticals Announces Closing of $25.0 Million Underwritten Offering
finance.yahoo.com - November 3 at 11:44 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-BioLine RX Ltd, Bellicum Pharma, MoneyGram
nasdaq.com - November 1 at 8:23 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-BioLine RX, Bellicum Pharma, Mohawk Industries
nasdaq.com - October 30 at 11:25 AM
seekingalpha.com logoBellicum Pharma slashes headcount by 79%
seekingalpha.com - October 29 at 10:43 PM
seekingalpha.com logoBellicum launches $25M underwritten offering
seekingalpha.com - October 29 at 10:43 PM
finance.yahoo.com logoBellicum Announces Interim BPX-601 Data and Corporate Restructuring
finance.yahoo.com - October 29 at 5:39 PM
finance.yahoo.com logoBellicum Announces $25.0 Million Underwritten Offering Priced At-The-Market
finance.yahoo.com - October 29 at 5:39 PM
finance.yahoo.com logoWells Fargo: These 2 Stocks Could Deliver Triple-Digit Wins
finance.yahoo.com - September 18 at 1:10 PM
nasdaq.com logoStock Alert: Bellicum Pharmaceuticals Soars 25%
nasdaq.com - September 15 at 1:11 PM
seekingalpha.com logoBellicum Pharmaceuticals, Inc. (BLCM) CEO Richard Fair on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 12:40 AM
Get Bellicum Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLCM and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:BLCM) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.